Combined use of dopamine and serotonin agonists in the treatment of allergic disorders
Patent 5502080 Issued on March 26, 1996. Estimated Expiration Date: 
November 1, 2014. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
November 1, 2014. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.Patent ReferencesMeans and method for aiding individuals to stop smoking Method of assisting weight loss Patent #: 4895845 InventorApplicationNo. 333294 filed on 11/01/1994US Classes:514/654, The chain consists of two or more carbons which are unsubtituted or have acyclic hydrocarbyl substituents only514/885IMMUNE RESPONSE AFFECTING DRUGExaminersPrimary: Cintins, Marianne M.Assistant: Jarvis, William R. A. Attorney, Agent or FirmInternational ClassA61K 031/135AbstractAllergic conditions are treated and allergic symptoms mitigated or resolved by the administration of a dopamine agonist such as fenfluramine and/or 5-hydroxytriptophan administered concurrently or in association with a serotonin agonist such as phentermine.Other References
| |
